As I expected there are some very encouraging signs and data covered in this quarterly newsletter. The number of tests is rising consistently and the number of clinicians ordering test is also on the increase.
The total number of tests for the year at over 31,000 certainly will be helping the inflow of money even though expenditure will still be higher as they pursue their marketing efforts.
I noticed yesterday that there was a market notice indicating that ANZ Investments had added about another 1% to their share holdings so that could be viewed as a positive sign as well.
Ann: Quarterly Update Q4 23 Test Volumes Reach New Record, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
8.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $64.95M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10450 | 8.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 10865 | 2 |
View Market Depth
| Last trade - 09.59am 25/06/2025 (20 minute delay) ? |
| PEB (ASX) Chart |
Day chart unavailable